MiStent SES® bioabsorbable
polymer stents help
improve outcomes

Sirolimus in crystalline form
provides controlled and
sustained drug elution in tissue

Product available
through key
distribution partners

Transforming medical devices for improved patient outcomes
TECHNOLOGY

Our proprietary technology utilizes supercritical fluids, which allow for prolonged therapeutic drug dosing after polymer absorption.

Read more...
PRODUCTS

Our products are designed to make clinically meaningful improvements in patient outcomes, and are available in select countries around the world.

Read more...
CLINICAL TRIALS

Our ongoing clinical trials are designed to confirm the effectiveness of our technology in interventional cardiology.

Read more...
LATEST NEWS

Watch the TCTMD panel discussion that addresses the question: Are All Bioabsorbable Stent Coatings the Same? Hear expert opinion on a novel approach that helps reduce disease progression and TLR catch-up phenomenon.

Panelists include Alexandra Lansky, M.D., Robbert de Winter, M.D., Ph.D., Elazer Edelman, M.D., Ph.D., and Martin Leon, M.D.

Watch video...